First Header Logo Second Header Logo

Connection

Girish Mishra to Adenocarcinoma

This is a "connection" page, showing publications Girish Mishra has written about Adenocarcinoma.
Connection Strength

1.267
  1. Trivedi AN, Levine EA, Mishra G. Adenocarcinoma of the appendix is rarely detected by colonoscopy. J Gastrointest Surg. 2009 Apr; 13(4):668-75.
    View in: PubMed
    Score: 0.275
  2. Mishra G. DNA analysis of cells obtained from endoscopic ultrasound-fine needle aspiration in pancreatic adenocarcinoma: Fool's Gold, Pandora's Box, or Holy Grail? Am J Gastroenterol. 2006 Nov; 101(11):2501-3.
    View in: PubMed
    Score: 0.237
  3. Mishra G, Zhao Y, Sweeney J, Pineau BC, Case D, Ho C, Blackstock AW, Geisinger K, Howerton R, Levine E, Shen P, Ibdah J. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc. 2006 Apr; 63(4):648-54.
    View in: PubMed
    Score: 0.228
  4. Mishra G, Butler J, Ho C, Melin S, Case LD, Ennever PR, Magrinat GC, Bearden JD, Minotto DC, Howerton R, Levine E, Blackstock AW. Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer. Am J Clin Oncol. 2005 Aug; 28(4):345-50.
    View in: PubMed
    Score: 0.217
  5. Mishra G, Liu TF, Frankel AE. Recombinant toxin DAB389EGF is cytotoxic to human pancreatic cancer cells. Expert Opin Biol Ther. 2003 Oct; 3(7):1173-80.
    View in: PubMed
    Score: 0.191
  6. Blackstock AW, Mornex F, Partensky C, Descos L, Case LD, Melin SA, Levine EA, Mishra G, Limentani SA, Kachnic LA, Tepper JE. Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer. 2006 Aug 07; 95(3):260-5.
    View in: PubMed
    Score: 0.058
  7. Monjazeb AM, Riedlinger G, Aklilu M, Geisinger KR, Mishra G, Isom S, Clark P, Levine EA, Blackstock AW. Outcomes of patients with esophageal cancer staged with [ยน8F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? J Clin Oncol. 2010 Nov 01; 28(31):4714-21.
    View in: PubMed
    Score: 0.019
  8. Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, Melin SA, Lovato J, Oaks T, Blackstock AW. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg. 2006 Apr; 243(4):472-8.
    View in: PubMed
    Score: 0.014
  9. Blackstock AW, Aklilu M, Lovato J, Farmer MR, Mishra G, Melin SA, Oaks T, Geisinger K, Levine EA. Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer. Int J Gastrointest Cancer. 2006; 37(1):7-14.
    View in: PubMed
    Score: 0.014
  10. Wentworth S, Russell GB, Tuner II, Levine EA, Mishra G, Waters GS, Blackstock AW. Long-term results of local excision with and without chemoradiation for adenocarcinoma of the rectum. Clin Colorectal Cancer. 2005 Jan; 4(5):332-5.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.